China

A snapshot of PrEP scale-up, registration and resources for China.

  • 800-1,000
    Estimated Number of Current PrEP Users

    Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

  • 797
    PEPFAR PrEP Target in COP 2019

    Targets are set by PEPFAR country teams on an annual basis. Targets do not indicate funding is available for PrEP.

Data Updated: May 1, 2019

Drug Registration Status

  • Gilead's Truvada (TDF/FTC) registration
    Not submitted
  • Generic versions of TDF/FTC for prevention
    Not submitted

Types of Projects

  • Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.
  • Implementation projects
  • National level — PrEP availability in government clinics.

Research, Demonstration and Implementation Projects

Funding

  • PEPFAR

Resources for China

  • A Framework for Scaling Up PrEP can help implementers, government and advocates begin planning for and implementing PrEP programs.
  • Click here for the latest information from the Chinese Ministry of Health.
  • APCOM is a coalition governments, United Nations agencies, non-profit organisations and community based organisations from Asia and the Pacific, working together to address HIV issues that affect the lives of men who have sex with men and transgender people. Click here to access PrEPMAP, their new guide to accessing PrEP in the region.